GlassScriptPhysician profile
Niloy Dasgupta
NPI 1215170972
$8,053.33
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.25 · 2020: $12.66 · 2021: $102 · 2022: $3,880 · 2023: $1,167 · 2024: $2,875.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,466 · Food and Beverage: $576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,465.63 |
| Food and Beverage | $576.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $2,604.73 | 2022 | |
| Terumo Medical Corporation | $1,630.12 | 2020-2024 | Glidesheath Slender, Hydropearl |
| Siemens Medical Solutions USA, INC. | $1,400.32 | 2022-2023 | |
| Medtronic, INC. | $1,257.27 | 2024 | Turbohawk, Hawkone |
| Cook Incorporated | $530.20 | 2022 | |
| Cook Medical LLC | $471.24 | 2022 | |
| Angiodynamics, INC. | $83.54 | 2021 | |
| Stryker Corporation | $34.41 | 2021-2022 | |
| Boston Scientific Corporation | $25.25 | 2023 | Idc |
| Ge Healthcare | $16.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Niloy Dasgupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.